# New Immunomodulatory Therapy Strategies in Chronic Reactive Arthritis

> **NCT00244179** · PHASE2 · UNKNOWN · sponsor: **Charite University, Berlin, Germany** · enrollment: 40 (—)

## Conditions studied

- Reactive Arthritis

## Interventions

- **DRUG:** interferon-gamma
- **DRUG:** infliximab
- **DRUG:** dmard

## Key facts

- **NCT ID:** NCT00244179
- **Lead sponsor:** Charite University, Berlin, Germany
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2003-01
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 40 (—)
- **Last updated:** 2006-09-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00244179

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00244179, "New Immunomodulatory Therapy Strategies in Chronic Reactive Arthritis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00244179. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*